Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

BACKGROUND: For patients with a higher burden of localized prostate cancer, radiation dose escalation with brachytherapy boosts have improved cancer control outcomes at the cost of urinary toxicity. We hypothesize that a focal approach to brachytherapy boosts targeting only grossly visualized tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Belliveau, C., Barkati, M., Delouya, G., Taussky, D., Beauchemin, M. C., Lambert, C., Beaulieu, L., Beliveau-Nadeau, D., Nicolas, B., Carrier, J. F., Vigneault, E., Ménard, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733116/
https://www.ncbi.nlm.nih.gov/pubmed/36494834
http://dx.doi.org/10.1186/s13014-022-02173-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733116/
https://www.ncbi.nlm.nih.gov/pubmed/36494834
http://dx.doi.org/10.1186/s13014-022-02173-5

Ejemplares similares